This article is intended to discuss the type of effects seen in the hemolymphopoietic system when cytokines are administered to animals. Although cytokine-induced changes in leukocytes are a prominent feature of cytokine administration to animals, they are definitely not the only types of cytokineinduced changes seen in animals. Additionally, a complete understanding of the hematologic effects of cytokines is only possible through the complementary study of both their in vivo and in vitro effects. Thus, for a fuller understanding of the pleiotropic nature of cytokines, both in vivo and in vitro, the reader is referred to several excellent review texts (36, 54, 67) .
CYTOKINE EFFECTS ON LEUKOCYTES
In general, the effects of cytokines on hemolymphopoietic cells include those affecting stimulation or depression of proliferation, enhancement of differentiation, promotion of endothelial adhesion, promotion of tissue infiltration, and those affecting (82) . In contrast, rHuTNF, given to rats for 1 wk, induced an anemia and marrow erythroid hypoplasia (81) . The anemia was characterized by decreased erythrocyte synthesis and reduced erythrocyte lifespan similar to the anemia of chronic inflammatory diseases (48) . These effects of rHuTNF are similar to those reported in mice in which 1 wk of treatment with rHuIL-1 induced a hypoproliferative anemia that could be corrected with erythropoietin (1, 33 (78) . However, de- creased numbers of marrow neutrophils are not seen with rHuIL-6-induced neutrophilia; thus, rHuIL-6 is not a neutrophil-releasing factor as are rHuIL-1, rHuTNF, and rHuG-CSF (74) . The first peak of IL-6-induced neutrophilia is therefore most likely due to demargination of peripheral neutrophils. This is consistent with the observation that the magnitude of this neutrophilia is very similar to that induced by epinephrine, a known demarginating agent in rats (77, 78) .
When evaluating effects of cytokines on the bone marrow, it is important to consider the entire hemolymphopoietic organ system, which in addition to bone marrow includes peripheral blood and spleen. For (7, 18) . Stimulatory effects of secondary cytokine release are seen in animals treated with rHuIL-1 and rHuIL-2. The thrombocytosis induced by IL-10 in mice is proposed to be secondary to induction of IL-6 (34) . IL-8 is released into the circulation in response to rHuIL-1 a injection in primates and influences circulating neutrophil populations (83) . Additionally, the eosinophilic hyperplasia seen in animals and humans treated with rHuIL-2 is an indirect effect of IL-2 because it is secondary to IL-5 production by IL-2-activated T cells (40) . Eosinophilia is T-cell-dependent, and the main controlling factor of eosinophilia, in IL-2 treated animals or in eosinophil-mediated disease, is IL-5, a T-cell-derived cytokine (57) . In contrast, inhibitory effects of secondary cytokine release also occur. For example, the administration of rHuIL-1/3 to primates over 2 or 7 days is myelostimulatory, whereas prolonged administration (14 days) is myelosuppressive due to induction of a serum inhibitory factor identified as TNF-a (24).
Cytokine-Induced Changes in Peripheral Blood
The types of alterations induced by cytokines in peripheral blood leukocytes include increased or decreased numbers of circulating leukocytes depending on the particular cytokine activity and the time of peripheral blood evaluation in relation to time of cytokine injection. The absolute number of peripheral blood leukocytes associated with cytokine treatment depends on a complex interaction of several variables. These include the effects of cytokines (71, 77) . When given daily for 1 wk to rats, rHuIL-1, rHuTNF-a, rHuTNF-(3, and rHuG-CSF induced peripheral neutrophilia and lymphopenia at 1.5-2 hr after injection or at 12-24 hr after injection of G-CSF (73, 75) . Recombinant HuIL-3 administered intravenously to rats as a single injection induced peripheral neutrophilia and monocytosis beginning at 4-6 hr after injection, peaking at 8 hr, and subsiding to normal by 12-24 hr (72) . Recombinant HuGM-CSF and rHuIL-3, when each was given individually to primates, caused neutrophilia (19, 20 (17) , and it has been proposed that the pulmonary sequestration and activation of GM-CSF stimulated neutrophils may be associated with endothelial damage. Consistent with this hypothesis is the dose-limiting toxicity of GM-CSF, a capillary leak syndrome manifest by edema, weight gain, and pleural and pericardial effusions (62) . IL-5 increases the surface expression of CD 11 b and increases the adhesion of eosinophils to human microvascular endothelial cells (57) . The showed little to no effect. Similarly, recombinant human interferon « (HuIFN-«) will not affect rodent cells, and no biologic effects are seen in in vivo studies with rHuIFN-a in rodents (i.e., rodent studies with rHuIFN-a were not predictive of the effects of rHuIFN-a in humans). However, a rHuIFN-a A/D hybrid is active on murine cells, and studies with this protein in mice did cause hematopoietic changes and was more predictive of the effects seen in humans with rHuIFN-a (53) . The use of homologous murine IFN-')' in rodents to predict the possible in vivo effects of human cytokines in humans has also been successful (27) . Human and murine IL-4 share only 50% amino acid sequence identity, and each of them is species-specific because they cannot bind to the other species' IL-4 receptor. However, Hu-IL-4 binds to and is active on monkey lymphocytes (8) .
Even though a cytokine may show cross-species reactivity, the effects in 1 species may not be predictive of effects in humans. For example, rHuIL-5 will promote eosinophil and B-cell differentiation in mice but only eosinophil differentiation in human cell cultures (57) . In contrast, HuIL-2 interacts with the IL-2 receptor of a wide variety of species, and in vivo studies with IL-2 in animals were predictive of the types of effects seen in humans with IL-2 (2-4). (23) . In those studies, rabbits immunized with human erythropoietin became anemic. It was shown that high antierythropoietin antibody titers in the rabbits interfered with endogenous red cell production, via inhibition of rabbit erythropoietin (58, 59 ). An 
